Bio Medica Laboratories Postpones Board Meeting to 13th Nov'26 for Half-Year Financial Results
Bio Medica Laboratories Ltd 路 Intimation 路 13 Nov 2026, 5:30 am
Bio Medica Laboratories Postpones Board Meeting to 13th Nov'26 for Half-Year Financial Results Bio Medica Laboratories Limited has postponed its Board of Directors meeting, originally scheduled for 5th Nov'26, to 13th Nov'26. The meeting has been rescheduled due to delays in finalizing the financial results. The board will convene to consider, approve, and take on record the company's standalone and consolidated financial results alongside the limited review report for the half-year ended 30th Sep'26.
Original exchange filing (PDF)
More announcements from Bio Medica Laboratories Ltd
- Monitoring Agency Report for the half year ended 30th September, 2026, issued by CARE Ratings Limited ( Monitoring Agency ), in respect of the utilization of proceeds raised through Initial Public Offer by the Company 路 14 Nov 2026
- Bio Medica Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Un-Audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the half year ended September 30, 2026 in terms of Regulation 33 of Securities and Exchange Board of India (Listing Obligation and Disclosure Requirement) 2015. 路 13 Nov 2026
- Bio Medica Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- Bio Medica Laboratories Limited has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 05 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 05 Nov 2026
- Non-Applicability of Corporate Governance Report for the 2nd Quarter Ended on 30th September, 2026. 路 26 Oct 2026
